Auxly Cannabis Group Inc. · TSX:XLY
Auxly Cannabis — Q4 2022 Earnings Presentation
15 slides from Auxly Cannabis's earnings presentation, Apr 3, 2023
Slide 1: Q4 2022 Earnings Presentation
This is Auxly Q4 2022 Earnings Presentation April 3rd, 2023
Slide 2: Disclaimers
Disclaimers Legal Disclaimer Forward-looking Information This the forward-looking information, general business, The information provided herein is not intended to corporate document contains economic and competitive uncertainties, provide financial, tax, legal or accounting advice. “forward-looking
Slide 3: Agenda
Agenda 1. 2022 Results 2. 2023 Strategic Goals 3. Q&A This is Auxly / Earnings Presentation 3
Slide 4: Speakers
Speakers Hugo Alves, JD Brian Schmitt, CPA, CFA Chief Executive Officer Chief Financial Officer This is Auxly / Earnings Presentation 4
Slide 5: Continued Growth and Progress
Auxly 2022 Continued Growth and Progress #5 Licensed Producer #1 In Cannabis 2.0 Product Sales
Slide 6: Focus on Key Product Categories
Evolving Consumer Needs Focus on Key Product Categories #1 in Vape Category (15.3% National Market #9 in Dried Flower Category (4.2% National Market Share) Share) #10 in Pre-Roll Category (2.8% National Market Share) 6
Slide 7: Brand Evolution To Drive Continued Growth
Consumer Focused Brands Brand Evolution To Drive Continued Growth Ultra-Value Value Mainstream Mainstream Premium Dried Flower, Milled Flower Dried Flower, Milled Flower, Pre- Vape, Edibles CBD Capsules, Oils, Topicals Dried Flower, Pre-Rolls, Vape, Rolls, Vape, Edibles Concentrates, Edibles Parcel
Slide 8: Key Product Category Innovation Focus in 2023
Focused Innovation to Drive Organic Growth Key Product Category Innovation Focus in 2023 30% Key Category Portfolio Increase in Q1 2023 30 New SKUs launched in H2 2022
Slide 9: Focusing on our High-Quality, Low-Cost Advantage for the Next Stage
Advanced Cultivation Focusing on our High-Quality, Low-Cost Advantage for the Next Stage Continuous Improvements in Product Quality and Yields Advanced Genetics R&D Program New Unique Genetics Driven by Consumer 9 Insights Launching in H1
Slide 10: Leveraging Scale and Automation
Advanced Manufacturing Leveraging Scale and Automation State-of-the-Art Automation Increased Manufacturing Capacity Consistent, High-Quality Product
Slide 11: Revenue Snapshot
Financial Performance Revenue Snapshot Auxly’s Net Revenue Auxly’s Full Year Revenue and Segment Overview (Thousands) (Thousands) $35,000 $100,000 $90,000 $80,000 $30,000 $70,000 $60,000 $50,000 $25,000 $40,000 $30,000 $20,000 $20,000 $10,000 $- $15,000 2021 2022 $10,000 $5,000 Flower & Pre- Vapes,
Slide 12: Earnings Overview
Financial Performance Earnings Overview Gross Profit Margin SG&A Net Loss1 (Thousands) 40% (Thousands) $50,000 $- 35% $45,000 -$20,000 30% $40,000 -$40,000 25% $35,000 -$60,000 20% $30,000 $25,000 -$80,000 15% 10% $20,000 -$100,000 $15,000 -$120,000 5% $10,000 0% -$140,000 $5,000 Q4 2021 Q4 2022 202
Slide 13: Growth and Profitability in 2023
2023 Strategic Goals Growth and Profitability in 2023 15% Increase in Net Revenue <40% Maintain SG&A to below 40% of NOR 35-40% Blended Gross Margins
Slide 14: Agenda
Agenda 1. 2022 Results 2. 2023 Strategic Goals 3. Q&A This is Auxly / Earnings Presentation 14
Slide 15: Auxly Cannabis Group Investor Relations
Auxly Cannabis Group 777 Richmond St W Unit 002 Toronto Ontario M6J 0C2 Investor Relations Direct Line 1 833 695 2414 Email ir@auxly.com